Essen BioScience is a world leader in the field of innovative cell-based assays, reagents, instrumentation and custom services for discovery research. Our specialities include phenotypic 'live content' kinetic imaging assays based around IncuCyte Zoom (e.g. angiogenesis, neurite outgrowth, cell migration/invasion, apoptosis etc.) and high throughput automated electrophysiology for ion channel drug discovery and safety (e.g. hERG assays). Our live content imaging solution has been adopted by laboratories across all 10 of the world’s top pharmaceutical companies as well as more than 150 leading biotechnology and academic research institutions.
Selcia Ltd headquartered in Ongar, Essex, UK, is a leading worldwide provider of contract research services. Selcia Discovery provides integrated small molecule drug discovery, including general medicinal chemistry and biology capabilities, applicable across all target classes with a particular strength in three unique and highly synergistic technologies: (1) medicinal chemistry on complex natural products; (2) capillary electrophoresis-based fragment and natural product screening; and (3) peptidyl-prolyl isomerase targets (cyclophilins, FKBPs, Pin1, together called PPIases). Selcia Radiolabelling specialises in GMP radiolabelled API and in 14C custom radiolabelling for metabolism, distribution and environmental fate studies.
No data available
No data available